amsacrine has been researched along with Remission, Spontaneous in 1 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty previously treated adults with lymphoma received AMSA as single agent therapy." | 1.26 | Initial experience with AMSA as single agent treatment against malignant lymphoproliferative disorders. ( Bodey, GP; Cabanillas, F; Freireich, EJ; Legha, SS, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabanillas, F | 1 |
| Legha, SS | 1 |
| Bodey, GP | 1 |
| Freireich, EJ | 1 |
1 other study available for amsacrine and Remission, Spontaneous
| Article | Year |
|---|---|
Initial experience with AMSA as single agent treatment against malignant lymphoproliferative disorders.
Topics: Aminoacridines; Amsacrine; Doxorubicin; Humans; Lymphoma; Remission, Spontaneous | 1981 |